跳至主要内容
临床试验/NCT05332132
NCT05332132Unknown不适用

Evaluation of the Heracure Device for Hysterectomy

Heracure Medical Ltd.1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2022年4月18日最近更新:
适应症

试验速览

阶段
不适用
入组人数
10
试验地点
1
主要终点
Device or procedure related Adverse Event (AE)

研究概览

简要总结

Safety and performance evaluation of the Heracure Device for intra-uterine morcellation after vaginal or laparoscopic hysterectomy.

详细描述

The purpose of this clinical investigation is to evaluate the safety and efficacy of the Heracure Device for intra-uterine morcellation after vaginal or laparoscopic hysterectomy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Subject is undergoing hysterectomy due to benign gynecologic disease

排除标准

  • Subject is not suspected of malignancy

结局指标

主要结局

Device or procedure related Adverse Event (AE)

时间窗: Intra-operation

Adverse Event defined as uterine perforation at the end of procedure, assessed by inflating the uterus with saline.

次要结局

  • Device Success(Intra-operation)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验